Role of immune checkpoint inhibitors in gastrointestinal cancer treatment

被引:3
作者
Riedl, Jakob Michael [1 ]
Stotz, Michael [1 ]
Gerger, Armin [1 ,2 ]
机构
[1] Med Univ Graz, Comprehens Canc Ctr Graz, Dept Med, Div Clin Oncol, Auenbruggerpl 15, A-8036 Graz, Austria
[2] Ctr Biomarker Res Med, Graz, Austria
关键词
Immunotherapy; Colorectal cancer; Esophageal cancer; Gastric cancer; Microsatellite instability; PD-1; BLOCKADE; NIVOLUMAB;
D O I
10.1007/s12254-019-0470-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this short review we aim to summarize the role current clinical role of immunotherapy in particular of immune checkpoint inhibition in gastrointestinal malignancies and highlight the most important clinical trials.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update
    DeCarli, Kathryn
    Strosberg, Jonathan
    Almhanna, Khaldoun
    CANCERS, 2022, 14 (17)
  • [42] The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy
    Ghidini, Michele
    Fusco, Nicola
    Salati, Massimiliano
    Khakoo, Shelize
    Tomasello, Gianluca
    Petrelli, Fausto
    Trapani, Dario
    Petrillo, Angelica
    CURRENT DRUG TARGETS, 2021, 22 (09) : 1021 - 1033
  • [43] The role of immune checkpoint inhibitors in prostate cancer
    Surdacki, Gabriel
    Szudy-Szczyrek, Aneta
    Goracy, Aneta
    Chyl-Surdacka, Katarzyna
    Hus, Marek
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2019, 26 (01) : 120 - 124
  • [44] The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer
    Martinez-Cannon, Bertha Alejandra
    Colombo, Ilaria
    CANCER DRUG RESISTANCE, 2024, 7 : 1 - 17
  • [45] Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective
    Lavacchi, Daniele
    Pellegrini, Elisa
    Palmieri, Valeria Emma
    Doni, Laura
    Mela, Marinella Micol
    Di Maida, Fabrizio
    Amedei, Amedeo
    Pillozzi, Serena
    Carini, Marco
    Antonuzzo, Lorenzo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 21
  • [46] The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer
    Martinez-Cannon, Bertha Alejandra
    Colombo, Ilaria
    CANCER DRUG RESISTANCE, 2024, 7
  • [47] Immune checkpoint inhibitors for metastatic bladder cancer
    Massari, Francesco
    Di Nunno, Vincenzo
    Cubelli, Marta
    Santoni, Matteo
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Cheng, Liang
    Lopez-Beltran, Anto
    Battelli, Nicola
    Ardizzoni, Andrea
    CANCER TREATMENT REVIEWS, 2018, 64 : 11 - 20
  • [48] Immune checkpoint inhibitors for nonsmall cell lung cancer treatment
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (01) : 7 - 14
  • [49] Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
    Zhang, Zhening
    Xie, Tong
    Zhang, Xiaotian
    Qi, Changsong
    Shen, Lin
    Peng, Zhi
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (03) : 287 - 302
  • [50] Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients
    Duffy, Michael J.
    Crown, John
    CLINICAL CHEMISTRY, 2019, 65 (10) : 1228 - 1238